Prices, pipelines and patent cliffs: Inside pharmas big reset – CNBC

CNBC

Image Credit: CNBC

Please find more details at CNBC

Summary

In this article LLY

NVO

NVO

SAN-FR

MRK-DE

NOV.N-CH

AZN-GB

PFE

AMGN

ROG-CH Follow your favorite stocks CREATE FREE ACCOUNT

This earnings season, Europes biggest pharma companies posted results ranging from 7% beats to 3% misses but no one really cared. Instead, drugmakers looked ahead, w…

Source: CNBC

Read More

(0)

Exclusive AI-Powered News Insights (For Members only)

Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!